Nrarp is a novel intracellular component of the Notch signaling pathway

  1. Elise Lamar1,
  2. Gisèle Deblandre1,
  3. Daniel Wettstein1,3,
  4. Volker Gawantka2,
  5. Nicolas Pollet2,
  6. Christof Niehrs2, and
  7. Chris Kintner1,4
  1. 1The Salk Institute for Biological Studies, San Diego, California 92186, USA; 2Division of Molecular Embryology, Deutsches Krebsforschungzentrum, D-69120 Heidelberg, Germany

Abstract

The Lin12/Notch receptors regulate cell fate during embryogenesis by activating the expression of downstream target genes. These receptors signal via their intracellular domain (ICD), which is released from the plasma membrane by proteolytic processing and associates in the nucleus with the CSL family of DNA-binding proteins to form a transcriptional activator. How the CSL/ICD complex activates transcription and how this complex is regulated during development remains poorly understood. Here we describe Nrarp as a new intracellular component of the Notch signaling pathway in Xenopus embryos. Nrarp is a member of the Delta–Notch synexpression group and encodes a small protein containing two ankyrin repeats. Nrarp expression is activated in Xenopus embryos by the CSL-dependent Notch pathway. Conversely, overexpression of Nrarp in embryos blocks Notch signaling and inhibits the activation of Notch target genes by ICD. We show that Nrarp forms a ternary complex with the ICD of XNotch1 and the CSL protein XSu(H) and that in embryos Nrarp promotes the loss of ICD. By down-regulating ICD levels, Nrarp could function as a negative feedback regulator of Notch signaling that attenuates ICD-mediated transcription.

Keywords

Footnotes

  • 3 Present address: Myriad Genetics, 320 Wakara Way, Salt Lake City, UT 84108, USA.

  • 4 Corresponding author.

  • E-MAIL Kintner{at}salk.edu; FAX (858) 450-2172.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.908101.

    • Received April 30, 2001.
    • Accepted June 4, 2001.
| Table of Contents

Life Science Alliance